In her debut blog, Aneta Zarska reviews a cohort study which looks at the links between death from COVID-19 and a range of mental health conditions, including schizophrenia, depression and anxiety.
[read the full story...]
“There are many other ways to get our patients better than prescribing and talking.”
Shuichi Suetani reviews a recently published textbook: The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry.
[read the full story...]
A group of MSc Clinical Mental Health Sciences students at UCL Psychiatry summarise a systematic review on the experience of initiating community-based group physical activity by people with serious mental illness.
[read the full story...]
Dolly Sud appraises a recent data linkage study on the impact of schizophrenia genetic liability on the association between schizophrenia and physical illness.
[read the full story...]
Zoe Stoneley reviews a Taiwanese study on nicotine replacement therapy and healthy lifestyle psychoeducation for smoking reduction in acute psychiatric inpatients.
[read the full story...]
Masuma Mishu from the Closing the Gap Network reviews a recent US trial of a comprehensive cardiovascular risk reduction intervention in people with severe mental illness, which shows promising results.
[read the full story...]
Gordon Johnston and Michel Syrett prepare for the #HealthSMI event on 24th June by blogging about a recent pilot RCT of a health coaching intervention (Walk This Way) to reduce sedentary behaviour and increase physical activity in people with serious mental illness.
[read the full story...]
Paul Heron from the Closing the Gap Network writes his debut blog about a 20‐year cohort study of physical morbidity and mortality in relationship to antipsychotic treatment in a huge group of people with schizophrenia in Finland.
[read the full story...]
A group of Masters Students from the University of Glasgow Global Mental Health MSc write about the Primrose trial, which looked at the clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk in severe mental illness.
[read the full story...]
Peter Haddad and Sami Ouanes review a network meta-analysis of the impact of antipsychotic drugs on metabolic function in people with schizophrenia.
[read the full story...]
